PMVP icon

PMV Pharmaceuticals
PMVP

Overview Fund Activity

115 hedge funds and large institutions have $470M invested in PMV Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 35 increasing their positions, 39 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
115
Holders Change
-5
Holders Change %
-4.17%
% of All Funds
1.86%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
13
Increased
35
Reduced
39
Closed
16
Calls
$1.88M
Puts
$727K
Net Calls
+$1.15M
Net Calls Change
+$961K

Top Buyers

1
Verition Fund Management
1
Verition Fund Management
Connecticut
$6.71M
2
Bank of America
2
Bank of America
North Carolina
$8.83M
3
Citadel Advisors
3
Citadel Advisors
Florida
$12M
4
UBS Group
4
UBS Group
Switzerland
$2.47M
5
Connor, Clark & Lunn Investment Management (CC&L)
5
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.01M

Top Sellers

1
RCM
1
RA Capital Management
Massachusetts
$0
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$6.78K
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$24M
4
JPMorgan Chase & Co
4
JPMorgan Chase & Co
New York
$35.6M
5
State Street
5
State Street
Massachusetts
$28.8M
Name Holding Trade Value Shares
Change 		Shares
Change %
PHK
126
Point72 Hong Kong
Hong Kong
– -$113K -9,512 Closed
Wells Fargo
127
Wells Fargo
California
– -$23K -1,888 Closed
QCG
128
Quadrant Capital Group
Ohio
– -$2K -179 Closed
HR
129
Howe & Rusling
New York
– -$1K -72 Closed
2 3 4 5
6